Friday, December 30, 2011
Thursday, December 29, 2011
FFN is finally starting to break out. The stock hit bottom in the low $.50's and has started to work its way higher. Today it was up over 20% on a breakout type move.
As I have stated many times, FFN has almost 20% of its tradeable shares short. The shorters have done well from $10 down to $.50, but at some point shorts have to cover to take their profits. Covering shorts = additional buying pressure and could lead to a "short squeeze" where over zealous shorts cover their positions. The question is are we at the start of this covering phase? or was today the final day and the stock will plunge to new depths tomorrow and into 2012?
I think there is a strong case for further gains. I particularly like how during this decline the stock has traded just under its 50DMA before taking out new lows. If this happens here we could see FFN rally to almost $1.20.
Today FFN traded 10% of its tradeable float at 776,346 , the float is 7.6 million shares.
The last reported amount of shares short is 1.18 million. These numbers are from almost a month ago. They could be different today.
I'll be watching for the increased volume to continue and I would not be surprised at all to see more of a squeeze tomorrow which could put this stock back over $1 a share and closer to its 50 DMA.
Today NXMR sat quietly, even briefly after an 8k hit the wires. It was then I noted the NXMR could see a similar type run-up as ASFX did yesteryday. ASFX had an 8k filed and I noted that stock in my chat room at $.0025 it went on to hit $.018.
Today it was NXMR that saw the buying pressure, but it didn't happen right away and those in the chat room were alerted to it right away before a single trade took place.
NXMR ended up running from $.0003 to $.005. The rally fizzled out at the close of the session, but the stock still ended the day much higher.
Wednesday, December 28, 2011
Tuesday, December 27, 2011
ALIM 1.28 ALIMERA SCIENCES
PSDV 1.21 PSIVIDA
FUQI 1.21 FUQI INTL
APPY 1.15 ASPENBIO PHARMA
CERP 0.98 CEREPLAST
PNCL 0.9402 PINNACLE AIRLINES
HOKU 0.53 HOKU
NYXO 0.18 NYXIO TECHNOLOGIES
DPTR 0.1611 DELTA PETROLEUM
BMBM 0.156 BMB MUNAI
OMVS 0.1 ON THE MOVE SYSTEMS
TBBC 0.034 BRAINY BRANDS CO
TUFF 0.017 TUFFNELL
EMBA 0.01 EMAMBA INTL
DUSS 0.0028 DUSSAULT APPAREL
ASFX 0.0022 AMERICAN SCIENTIFIC RESOURCES
CMGR 0.0002 CAMELOT ENTERTAINMENT GROUP INC
MNDP 0.0002 MUNDUS GROUP
Last trade $.19 for NYXO. The chart is looking much better after a nice drop from over $1 a share in September. The $.26 50 DMA is the point of next resistance. If this rally does come to fruition a quick 25-40% gain, possibly much more, is not out of the question.
Monday, December 26, 2011
UNDT signs agreement with Honeywell India to develop radiation detector Comtex News Network "Datamonitor"
Dec 27, 2011 (Datamonitor via COMTEX) -- Universal Detection Technology , or UNDT, a developer of monitoring technologies, has entered into an agreement with Honeywell India, a unit of Honeywell International , to develop a radiation detector which would display radiation data collected via Bluetooth to a smart phone.
The product is designed to detect radiation levels on surfaces and food and to automatically send the collected data to a smartphone. The instrument in development will utilize a Cesium Iodide (CsI) scintillator for the detection of Gamma rays, the company said.
The device is expected to measure elevated levels of gamma radiation, transmit that data to a Bluetooth-ready smart phone, and give the user the ability to share the accumulated data with others through mapping and social networking features. The device will be easy to use for everyday users but also have the sensitivity to be utilized in the nuclear industry and HAZMAT crews. Preliminary estimates are that the device would be ready for commercial use in the second quarter of 2012, the company added.
The new device will be owned and marketed by Universal Detection Technology , under its brand. According to the agreement, any and all intellectual property including any patents which may be filed will be the sole property of Universal Detection Technology .
"The accident at the Fukushima Daiichi nuclear plant and the subsequent release of radiation exposed the unpreparedness of the radiation detection industry with its outdated detection technologies," said Amir Ettehadieh , UNDT's Director of R&D. "We envision that the market is ready for a device that is compact, easy to use, and is compatible with a smartphone and can be used by anyone from a housewife to a nuclear industry professional," he added.
As of Nov 30th almost 20% of the float is short. Considering the stock has fallen since then, its safe to say there are many more shorts in this stock then 3 weeks ago, which begs to question when they will cover? Friday's high volume breakout could be the start of a nice squeeze higher for this stock. We could see buyers step in, shorts cover, and an overall lack of supply lead to a nice jump in price per share.
I do think this $.55 stock will bounce back over $1.
Next up FFN.
Wednesday, December 21, 2011
WRIT lets see if we can get a move back over $.01. Volume history shows this stock won't need too much buying pressure to get it out of sub-penny land.
TLAN the company has done so many positive things in 2011 including reducing the share count on more than two occasions. Currently at $.001 this stock could be one of those huge sub penny stock runners. Patience is difficult in this market but can also pay of handsomely.
FFN there is a large short position in this $.54 stock. I think it comes back soon and goes over $1. Let's see if I know what I am talking about.
AERN this is the next 'A' stock runner. At $.0056 this looks a lot like ALZM and it has the potential to pull a similar move.
WRIT soared 250% today closing at $.0042 after hitting $.0045 and I was quick to bring it to the attention of my chat subscribers at $.0013 before it traded any shares. This was just another day of a news runner, as was ALZM which I also brought to my chat subscribers attention at $.011. It hit $.0559 today. To put that type of move into perspective a $1,100 investment would have turned into $5,559 at today's highs.
I have great intuition and knowledge about the market. I know when stocks will move and when they won't. Lets see what 200%+ news stock tomorrow brings.
Lets face it, ALZM is going back under $.01 soon, but it was nice to see it not only hold gains, but surge mid session. The stronger volume, but lack of a more substantial move, in my view, means fresh shares are hitting the market. Just something to be wary of. Being up over 200%, now is not the time to be diving into this stock. It time to be finding the next one.
Symbol Last Company Name
APPY 1.35 ASPENBIO PHARMA
FUQI 1.35 FUQI INTL
ALIM 1.22 ALIMERA SCIENCES
PSDV 1.19 PSIVIDA
BDSI 0.89 BIODELIVERY SCIENCES
PNCL 0.845 PINNACLE AIRLINES
CERP 0.81 CEREPLAST
FFN 0.535 FRIENDFINDER NETWORKS
HOKU 0.51 HOKU
RNN 0.45 REXAHN PHARMACEUTICALS
RODM 0.44 RODMAN & RENSHAW CAPITAL
DPTR 0.17 DELTA PETROLEUM
NYXO 0.155 NYXIO TECHNOLOGIES
AAGC 0.124 ALL AMERICAN GOLD
OMVS 0.0885 ON THE MOVE SYSTEMS
RGRX 0.08 REGENERX BIOPHARMA
GRHU 0.0535 GREENHOUSE HOLDINGS
ALZM 0.04 ALLEZOE MEDICAL HOLDINGS
TBBC 0.04 BRAINY BRANDS CO
EMBA 0.01 EMAMBA INTL
MSMY 0.0032 MC ENDVRS
EVCA 0.0002 EVCARCO
MNDP 0.0002 MUNDUS GROUP
Tuesday, December 20, 2011
In the low $.01's today I noted in the chat room that $.02 was well within reach, and once it hit that mark it that price acted as support before gaining strength later in the afternoon.
ALZM closed right at the high of the session with $.039 going through afterhours.
Allezoe Medical Holdings (ALZM) Completes Exclusive Licensing Deal for HPV Diagnostic Technology Marketwire "Press Releases"
BOCA RATON, FLORIDA -- (MARKET WIRE) -- 12/20/11 -- Allezoe Medical Holdings , Inc. (OTCBB: ALZM) announces that it has acquired the exclusive license to develop and market patent pending, advanced "see and treat" diagnostic technology for Human papillomavirus (HPV), the world's leading sexually transmitted infection (STI). An exclusive license has been signed by SureScreen Medical, Inc. , a wholly-owned subsidiary of Allezoe, and AVM Corp. , which recently acquired the technology and the pending patent application from its developer, Aequorea Vision Medical, Inc. Under the terms of the license, SureScreen will develop and market products worldwide using the technology in return for a fixed royalty to AVM, commencing on sales of products using the technology.
As a result of the license, Allezoe now holds the exclusive worldwide rights to this groundbreaking "see and treat" technology which will allow healthcare providers to identify cell damage from HPV instantaneously, bypassing the long lab wait times, fees and additional patient discomfort found in existing HPV diagnostic methods on the market, including the Pap smear.
With this license and the global marketing and distribution strategy it is developing, Allezoe will be positioned to enter its market. In the United States alone, there is a $6 billion annual diagnosis and treatment market for HPV, and the market is increasing under growing national attention to the virus. Recently, the Centers for Disease Control and Prevention has recommended the HPV vaccine be used for men as well. Allezoe's technology is a crucial counterpart to the vaccine, identifying any preexisting damage before vaccine administration; importantly, it also offers an important alternative for those who avoid the vaccine due to controversial side effects.
Infecting 233 million women worldwide, the virus is the leading cause of cervical cancer in women, which often results in death. HPV is known to cause a growing number of cancers and lesions in both genders, including cervical, neck, and throat cancer. More recently, HPV is being researched as a possible cause of heart disease. Allezoe's technology is a one-stop HPV solution for patients and their providers. Allezoe's HPV technology will be welcome in the United States , where healthcare costs are a growing concern. It has important implications for healthcare abroad and in poorer nations where patients do not have the luxury of making repeated visits to a clinic or waiting several days for a Pap smear report from a distant laboratory.
Allezoe CEO Michael Gelmon says, "This is not a virus we have the luxury of ignoring, when hundreds of millions of people around the world are affected and are further spreading the virus. Our new licensed technology offers the combination of accuracy plus efficiency. This is a large market that we are looking forward to penetrating, and we have a strategy in place so we can hit the ground running."
About Allezoe Medical Holdings
Allezoe Medical Holdings, Inc. (OTCBB: ALZM) is a holding company focused on acquiring the most high quality and in-demand medical products, solutions and services. Whether through diagnosis, treatment, or medical research itself, Allezoe is interested in companies that are making a striking difference in the healthcare system through technology and treatments for health issues that affect large populations. For more information, please visit www.allezoe.com.
Safe Harbor Statement
This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21 E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that these forward-looking statements involve uncertainties and risk that could cause actual performance and results of operations to differ materially from those anticipated. These risks are set forth in the Company's most recently filed form 10-K and Form 10-Q reports. The Company assumes no obligation to update the statements contained in this release except as required by applicable securities disclosure rules. The Company's SEC filings are available at http://www.sec.gov.
Add to Digg Bookmark with del.icio.us Add to Newsvine
Contacts: Allezoe Medical Holdings, Inc. Media Department firstname.lastname@example.org www.allezoe.com
Monday, December 19, 2011
FFN - $.56
Stock has fallen from over $10 this summer. Almost 20% of the float is short as reported at the end of November up sharply from the middle of November. I would not be surprised if there were even more shares shorted since then. If the stock does indeed bounce, we could see a significant short squeeze.
APPY 1.4 ASPENBIO PHARMA
FUQI 1.36 FUQI INTL
PSDV 1.1 PSIVIDA
COMV 1.08 COMVERGE
BDSI 0.98 BIODELIVERY SCIENCES
PNCL 0.958 PINNACLE AIRLINES
CERP 0.8 CEREPLAST
GLGL 0.607 GLG LIFE TECH CORP
HOKU 0.6 HOKU
RODM 0.44 RODMAN & RENSHAW CAPITAL
ENER 0.21 ENERGY CONVERSION DEVICE
DPTR 0.1757 DELTA PETROLEUM
NYXO 0.15 NYXIO TECHNOLOGIES
OMVS 0.12 ON THE MOVE SYSTEMS
AAGC 0.12 ALL AMERICAN GOLD
AERG 0.0501 APPLIED ENERGETICS
TBBC 0.048 BRAINY BRANDS CO
EMBA 0.0137 EMAMBA INTL
ALZM 0.011 ALLEZOE MEDICAL HOLDINGS
AERN 0.0067 AER ENERGY RESOURCES
CMGR 0.0001 CAMELOT ENTERTAINMENT GROUP INC
KING OF PRUSSIA, Pa., Dec. 19, 2011 /PRNewswire via COMTEX/ -- Medical Alarm Concepts Holding, Inc. (OTCQ:MDHI), manufacturer of the MediPendant(TM), the first fully-monitored medical alarm system that allows you to speak and listen directly through the pendant, today announced its plans to promote the MediPendant(TM) utilizing an ecommerce marketing strategy program designed specifically for Costco and its members.
Costco is the largest membership warehouse club in the United States. According to their 2010 annual report, Costco had 58 million members worldwide. Under the terms of the contract, Costco will be marketing and promoting the MediPendant(TM) to its existing customer base on the Costco.com website, in their subscriber magazine, The Costco Connection, as well as a few other initiatives that have yet to be finalized.
"There is a great fit for our product, the MediPendant(TM) and the Costco customer. We are very excited that Costco chose the MediPendant(TM) over several other medical alarm devices they reviewed," said Paul Green, VP Sales and Marketing of Medical Alarm Concepts Holding. "Both Costco and Medical Alarm Concepts are very customer service oriented, and want to make sure that the customer gets the best product, with the best services, for the best value," adds Green.
Currently, Medical Alarm Concepts(TM) is working with Costco's marketing team to get the final details of the MediPendant(TM) program in place. The campaign is scheduled to begin in January 2012.
About Medical Alarm Concepts
BEIJING, Dec. 19, 2011 /PRNewswire via COMTEX/ -- Wowjoint Holdings Limited ("Wowjoint," or the "Company") (Nasdaq: BWOW, BWOWU, BWOWW), China's innovative infrastructure solutions provider of customized heavy duty lifting and carrying machinery, today announced that certain of its Executive Officers will conduct purchases of the Company's stock on the open market ("Purchase Plan").
Yabin Liu, Chief Executive Officer & Director; Fude Zhang, Chief Technology Officer & Director; and Liguo Liu, Senior Vice President of Marketing will be participating in the Purchase Plan. Between January 1, 2012 and June 15, 2012 these executives will collectively purchase up to $200,000 worth of shares on the open market, which as of the closing price on December 15, 2011 is approximately 500,000 shares. These purchases will occur each month, with a minimum of 5,000 shares purchased during each month.
"Our executive officers believe that the Company's stock is greatly undervalued and we have a strong conviction for Wowjoint's future success. We are dedicated to the Company and are demonstrating our dedication through buying stock in the open market," stated Mr. Yabin Liu, Chief Executive Officer of Wowjoint. "We've discussed our desire to conduct an executive stock purchase with the board of directors following the determination that it's not the best use of Wowjoint's current cash to conduct a stock buyback, as its best used for business expansion purposes. The board supports our decision and we look forward to commencing our Purchase Plan at the beginning of the year."
Friday, December 16, 2011
Wednesday, December 14, 2011
News out today (pasted below) helped propel this stock to $.0006 before an ultimate close at $.0004.
OMAHA, Neb., Dec. 14, 2011 /PRNewswire via COMTEX/ -- TiVUS, Inc. (OTCPK: TIVU) today announced it has posted its successfully completed independent audit of its fiscal years 2009 and 2010, at OTC Markets Group (www.otcmarkets.com).
"We are pleased our PCAOB-compliant audit was concluded successfully," commented Shiva Prakash, TiVUS' chief executive officer. "With this important milestone behind us, we can move forward with all necessary regulatory filings to register our securities and become a fully reporting public company under the United States Securities & Exchange Commission (SEC).
"In conjunction with the audit's completion, we are currently preparing SEC Form 10 to register our securities and qualify for an up-list market tier on the OTC Markets trading platform from OTCPK to OTCQB."
The OTCQB market tier helps investors easily identify companies that are current in their reporting obligations with the SEC. OTCQB securities are quoted on OTC Markets Group's quotation and trading system and some may also be quoted on FINRA's Bulletin Board. See OTCQB Fact Sheet here.
"With ad-sales, the final phase of our hotel HD IPTV with ad-insertion deployment, currently underway, we expect the Company to soon reach another highly anticipated milestone as the Company's first ad-revenues begin this month," Prakash concluded.
About TiVUS, Inc.
Symbol Last Company Name
PSDV 1.17 PSIVIDA
PNCL 1.1324 PINNACLE AIRLINES
COMV 1.09 COMVERGE
BDSI 0.995 BIODELIVERY SCIENCES
HYFXF 0.87 HYFLUX LTD
GLGL 0.848 GLG LIFE TECH CORP
CERP 0.8099 CEREPLAST
CPHI 0.76 CHINA PHARMA HOLDINGS
HOKU 0.67 HOKU
DHT 0.66 DHT HOLDINGS
FFN 0.6081 FRIENDFINDER NETWORKS
PURE 0.48 PURE BIOSCIENCE
RNN 0.47 REXAHN PHARMACEUTICALS
RODM 0.4668 RODMAN & RENSHAW CAPITAL
DPTR 0.3722 DELTA PETROLEUM
HEAT 0.34 SMARTHEAT
OMVS 0.178 ON THE MOVE SYSTEMS
AAGC 0.125 ALL AMERICAN GOLD
TKDN 0.11 TAKEDOWN ENTERTAINMENT
AERG 0.08 APPLIED ENERGETICS
GRHU 0.055 GREENHOUSE HOLDINGS
GAPTQ 0.048 GREAT ATLANTIC & PACIFIC
TBBC 0.045 BRAINY BRANDS CO
TUFF 0.0239 TUFFNELL
ALZM 0.018 ALLEZOE MEDICAL HOLDINGS
NRTLQ 0.0174 NORTEL NETWORKS
EMBA 0.012 EMAMBA INTL
Tuesday, December 13, 2011
SEC Charges "Shell Packagers" and Several Others in Penny Stock Scheme
Washington, D.C., Dec. 12, 2011 – The Securities and Exchange Commission today charged a shell packaging firm and several others involved in a penny stock scheme to issue purportedly unrestricted shares in the public markets.
The SEC alleges that Joseph Meuse and his firm Belmont Partners LLC – which is in the business of identifying and selling public shell companies for use in reverse mergers – fabricated and backdated documents used to convince a transfer agent and an attorney writing an opinion letter to issue free-trading shares of Alternative Green Technologies Inc. (AGTI). The SEC also charged AGTI and its CEO Mitchell Segal as well as Segal’s business partner Howard Borg and stock promoters David Ryan, Vikram Khanna, and Panascope Capital Inc. for their roles in the scheme that resulted in unknowing investors purchasing fraudulently issued AGTI shares without the protections afforded by the securities laws.
“Shell packagers who buy and sell public companies for use by fraudsters have no rightful place in our markets,” said David Rosenfeld, Associate Director of the SEC’s New York Regional Office. “These shell packagers not only sold the shell company, but created the false documents necessary to cause the transfer agent to issue shares that should never have been sold to the public.”
According to the SEC’s complaint filed in U.S. District Court for the Southern District of New York, Long Island, N.Y.-based AGTI and Segal, an attorney licensed to practice in New York, knowingly submitted false documents to a transfer agent and an attorney, who relied on them to conclude that free-trading shares of AGTI could legitimately be issued. Virginia-based Belmont Partners and Meuse aided and abetted AGTI’s fraud by knowingly creating and sometimes backdating the false documentation, including a sham assignment of debt and a fabricated and backdated corporate resolution and convertible note. Segal then used the stock certificates illegally issued to fund promotional campaigns promoting AGTI’s stock. The stock promoters – Ryan, Panascope Capital and its president Khanna – were charged with selling the unregistered securities.
The SEC’s complaint charges all defendants with violating Section 5 of the Securities Act of 1933, and AGTI and Segal with violating Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5(a) and (c) thereunder. Segal, Meuse and Belmont Partners are charged with aiding and abetting the fraud by AGTI. The SEC’s complaint seeks permanent injunctions and disgorgement against all defendants; a financial penalty against AGTI, Segal, Belmont Partners, Meuse, and Ryan; and officer and director and penny stock bars against Segal and Meuse. The SEC’s complaint also names several relief defendants for the purposes of recovering proceeds they received from the illicit stock sales.
Borg, Khanna and Panascope Capital have consented to the entry of a final judgment enjoining them from further violations of Section 5 of the Securities Act without admitting or denying the allegations in the SEC’s complaint. Khanna and Panascope Capital agreed to pay $81,477.10 to settle the charges, and Borg agreed to pay $35,264.05 and surrender to the transfer agent for cancellation more than four million shares of AGTI stock that were illegally issued. The settlements are subject to court approval.
The SEC’s investigation was conducted by Megan Genet and Steven G. Rawlings of the SEC’s New York Regional Office. The SEC’s litigation effort will be led by Todd Brody and Megan Genet.
The Reporting Person acquired the 107,295,236 shares of common stock in open market transactions through his brokerage account(s) for a total of $134,091.70 paid for them or $.0012 a share. Today the stock closed at $.0004. I think the stock remains one to watch considering the heavy buying we've seen from Amir. If this keeps up, and the company stops diluting, we could see a sharp rally from here.
Monday, December 12, 2011
Symbol Last Company Name
PSDV 1.35 PSIVIDA
PNCL 1.1711 PINNACLE AIRLINES
BDSI 1.07 BIODELIVERY SCIENCES
USAT 1.03 USA TECHNOLOGIES
CERP 1 CEREPLAST
CPHI 0.8 CHINA PHARMA HOLDINGS
VALV 0.795 SHENGKAI INNOVATIONS
HOKU 0.7654 HOKU
DHT 0.73 DHT HOLDINGS
FFN 0.6505 FRIENDFINDER NETWORKS
RNN 0.5125 REXAHN PHARMACEUTICALS
PURE 0.44 PURE BIOSCIENCE
DPTR 0.43 DELTA PETROLEUM
HEAT 0.3551 SMARTHEAT
ROSG 0.25 ROSETTA GENOMICS
OMVS 0.181 ON THE MOVE SYSTEMS
TKDN 0.15 TAKEDOWN ENTERTAINMENT
AERG 0.081 APPLIED ENERGETICS
GRHU 0.0589 GREENHOUSE HOLDINGS
GAPTQ 0.05 GREAT ATLANTIC & PACIFIC
ALZM 0.0383 ALLEZOE MEDICAL HOLDINGS
TUFF 0.0279 TUFFNELL
NRTLQ 0.0157 NORTEL NETWORKS
FOGC 0.0005 FORTUNE OIL & GAS
PGIE 0.0002 PGI ENERGY
Thursday, December 8, 2011
KAMMONA AMIR purchased another 930k of ONTC stock at $.0008 today bringing his total to just over 98 million shares.
The stock closed up 40% higher, and was up at $.0009 earlier in the session.
FTCH has posted an impressive two day rally from sub $.001 to a close of $.0032 today. News out today helped propel the stock higher. There was also news out yesterday.
ALPHARETTA, Ga., Dec. 8, 2011 /PRNewswire via COMTEX/ -- F3 Technologies, Inc. (Pinksheets: FTCH.PK) today announced it has released the newly redesigned FargoTube.com, the premier social network for consumers to enjoy and discuss premium digital entertainment and streaming artistic content.
"Following FargoTube's migration to our new lightning-fast FargoCloud(TM) streaming and distribution platform and the recent addition of more than 10,000,000 new music tracks, I am pleased to announce the timely release of our newly redesigned FargoTube.com 3.0," commented Frank Connor, F3 Technologies' chief executive officer. "We believe fans and artists will enjoy the new look and feel as well as appreciate the site's enhanced speed and streamlined user experience.
"Fans will also discover newly added book and movie sections, allowing for authors and producers to add their works. The new site launches with over 200,000 book titles and the platforms first movie deal under its wing. Consumers can expect to see more content acquisitions in the weeks to come in addition to the millions of music tracks, artist 'Tubes,' and fan sites currently ready for enjoyment. With both free and premium content, we believe FargoTube has something for everyone."
What has not changed is that FargoTube remains a unique platform for artists and creative professionals to connect with fans and easily manage their sales and royalties, merchandising, and online fan presence without any up-front costs.
Since its launch 2 years ago, FargoTube has been actively acquiring premium content from signed and independent artists alike. Now, fueled by the tremendous growth of content and viewership, FargoTube has evolved into a performance stage showcasing its extensive library of premium music, video, books, and movies.
"Our current growth allows for greater varieties of premium content demanded by the growing 14 - 45 year-old consumer base who increasingly purchase most of their digital entertainment online," Connor concluded.
We can end the LEXG comparison today. After soaring some 87% today to $1.39, a late press release caused investors to dump the stock. The company responded with a press release of their own after hours. I have posted both below:
LOS ANGELES, Dec 8, 2011 (GlobeNewswire via COMTEX) -- Private investor, George Sharp, who has filed a civil action (Los Angeles County Division of California Superior Court Case No. BC461550) for Fraud, Negligent Misrepresentation, violation of California Corporations Code Section 25400, and violations of the California Business and Professions Codes 17200 (Unfair Business Practices) and 17500 (False Advertising) against Writers' Group Film Corp., Inc. ("Writers' Group") (PINK SHEETS:WRIT), its wholly owned subsidiary Front Row Networks, Inc ("Front Row"), and its current and former officers, announced today that several new Defendants have been added to his lawsuit.
According to Mr. Sharp, the naming of additional Defendants comes after he examined Writers' Group President and CEO, John Diaz, in a deposition in front of a court reporter on Tuesday, November 29, 2011.
Amongst the newly identified Defendants in the litigation are Armada International, Inc, Michael Sullivan, and Amwest Imaging, Inc (OTCBB: AMWI) insider, Phil Keuber and Christa Keuber, believed to be Phil Keuber's wife .
Mr. Sharp commented, "As a result of my research and Mr. Diaz's sworn testimony, I am now convinced that the newly added Defendants conspired to defraud the public by conducting what is commonly known as a Pump and Dump scheme. I believe that they executed a ruse in which Mr. Diaz was to receive financing and support from the Defendants for his projects, which were vended into Writers' Group, and once the Defendants divested themselves of their shares, the financing and support stopped. I believe that the Defendants used Mr. Diaz's reputation and background to their advantage and installed him as a figurehead while dumping their shares onto the public. Certified documents from the company's transfer agent show that on February 11, 2011, Diaz, Keubers, Sullivan and Armada collectively owned 110,000,000 of the 110,130,750 shares of Writers' Group issued and outstanding. On March 7, 2011, the day that the Writers' Group promotional campaign began in earnest, over 100,000,000 shares traded. These shares could only have come from some or all of the insiders. I am currently in the process of subpoenaing the transfer agent's records for the entire year." Mr. Sharp also noted that, in the course of his deposition, Mr. Diaz testified, under oath, that he has not divested himself of any Writers's Group stock and has offered to produce his original certificates as evidence.
Mr. Sharp, expressed concerns for investors of Amwest Imaging, an issue currently undergoing a heavy promotion campaign. According to the website www.pumpsanddumps.com, a website that has wrongly linked to Mr. Sharp, Amwest Imaging is following the same pattern as the Writers' Group scheme. As virtually all of Writers' Group stock was held by four individuals prior to its promotion, pumpsanddumps claims that SEC filings show that Mr. Keuber and his associates held 100% of of Amwest Imaging stock and that company installed a new President immediately before the promotion began, in order to give the appearance that Mr. Keuber has an arms-length relationship with the company.
Mr. Sharp added, "It is more than just a little disconcerting that both companies, as well as other failed public companies involving Mr. Keuber that have also undergone promotion campaigns, all share the same Beverly Hills address, and retain the services of corporate attorney, Ron Stauber."
In order to offer full disclosure, Mr. Sharp revealed that he is a former shareholder of Amwest Imaging, having divested himself of his stock once he realized Mr. Keuber's relationship to the company. Mr. Sharp currently holds no interest in Amwest Imaging stock.
Further and ongoing information about this lawsuit and a copy of the complaint as well as the aforementioned motion and opposition can be obtained at the website: www.sharp-v-writ.info . Get instant alerts about this lawsuit by becoming a follower at www.twitter.com/goniffs .
This news release was distributed by GlobeNewswire, www.globenewswire.com
EVANSVILLE, IN, Dec 08, 2011 (MARKETWIRE via COMTEX) -- Amwest Imaging Incorporated (OTCBB: AMWI) was the subject of a press release issued today by a George Sharp. Mr. Sharp has indicated that he has named the Company (and others) as an additional defendant in his lawsuit against Writers' Group Film Corp., Front Row Networks, Inc., Tal Kapelner, Ariella Kapelner, John Diaz and Does 1 through 50, inclusive, in the Superior Court of the State of California, County of Los Angeles, Central District, Case Number BC 461550.
Mr. Sharp's press release contains numerous misstatements of facts attributed directly to Mr. Sharp to include where the Company is located, the nature of the ownership of the Company, alleged relationships to others and a defamatory assertion that the Company is not successful. The Company is informed and believes that Mr. Sharp has filed similar civil actions against numerous other public companies alleging fraud, misrepresentation, violation of California Corporations Code and Business and Professions Code.
Mr. Sharp has indicated that he is a former shareholder of the Company. The Company has no relationships with any of Mr. Sharp's aforementioned named defendant companies or aforementioned named individuals. Mr. Sharp is not represented by counsel. The Company has not been served with the complaint.
The Company is examining its legal options which may be, but are not limited to, a lawsuit being filed with significant damages being sought. The Company intends to do everything possible to protect its shareholders from the potential damages caused as a result of this legal action.
Wednesday, December 7, 2011
I see some newsletters comparing AMWI to LEXG and I think they are wrong as far as price goes. While both stocks started out as completely dead and dormant, there are a few differences. For those that don't know LEXG, I was the first to spot this stock at $.10 a share it ultimately went over $10 a share in spectacular fashion.
Read about it here: http://pennystockgurus.blogspot.com/2011/04/lexg-87-bagger-and-counting.html
The difference between LEXG and AMWI on the surface is money flow and volume. AMWI is already hitting close to 30 million in volume a day. If AMWI were to hit $2 or $3 a share your looking at $100-125 million in daily volume. I just don't see that happening. I do think the stock has a decent shot at $1 and could see $2 at the current rate of buying interest, but $5 or even $10, it would take some enormous money flow for a stock that was DEAD only weeks ago.
While there are differences there are similarities, such as LEXG and AMWI both being dead with virtually zero volume until a buying switch gets flipped and instantly liquidity appears. LEXG was an amazing rally and one that every promoted stock would love to be compared to.
On November 1st, 2011 AMIR KAMMONA reported via a Form 3 that he had acquired 27,109,502 shares of Common Stock in open market transactions through his brokerage account. From that date until today's new Form 4 AMIR KAMMONA has increased his stake in ONTC more than 3 fold and now holds close to 100 million shares of stock all of which have been purchased in the open market since November 1st and are valued at close to $60,000 as of today's close.
Today's 2 million and 800k purchased by Amir show up on today's ONTC tape at 9:57 and 11:35 so they are indeed real. Some great questions: Who is AMIR Kammona , why is he buying up ONTC stock with such vigor, and will he continue to buy more? Stay tuned.
Tuesday, December 6, 2011